ArticlePatient preference and adherence2013

Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine.

Raymond Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.